CorMedix (CRMD) Times Interest Earned (2010 - 2026)
CorMedix (CRMD) posted Times Interest Earned of -$62.37 for Q4 2025, down 34114.17% sequentially from $0.18 in Q3 2025, and down 104.63% YoY from $1347.3 in Q4 2024.
CorMedix (CRMD) Times Interest Earned (2010 - 2026) Analysis & Trends
CorMedix has reported Times Interest Earned for 15 years, with the latest figure at -$62.37 in Q4 2025.
- Quarterly Times Interest Earned fell 104.63% year-over-year to -$62.37 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$170.47 (up 10.67% YoY) and the FY2025 annual result came in at $1.32, up 239.66% from the prior year.
- Times Interest Earned declined to -$62.37 in Q4 2025 per CRMD's latest filing, from $0.18 in the prior quarter.
- Over five years, Times Interest Earned peaked at $1347.3 in Q4 2024 and troughed at -$2390.0 in Q4 2023.
- A 5-year average of -$296.35 and a median of -$63.42 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned plunged 111912.64% in 2022, then soared 156.37% in 2024.
- Over 5 years, Times Interest Earned stood at -$1446.6 in 2021, then soared by 96.8% to -$46.28 in 2022, then sank by 5063.87% to -$2390.0 in 2023, then soared by 156.37% to $1347.3 in 2024, then tumbled by 104.63% to -$62.37 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$62.37, $0.18, and $8.19 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.85 |
| Dec 31, 2025 | -62.37 |
| Sep 30, 2025 | 0.18 |
| Jun 30, 2025 | 8.19 |
| Mar 31, 2025 | 37.97 |
| Dec 31, 2024 | 1,347.26 |
| Sep 30, 2024 | -64.46 |
| Jun 30, 2024 | -90.54 |
| Mar 31, 2024 | -98.84 |
| Dec 31, 2023 | -2,389.99 |
| Sep 30, 2023 | -209.35 |
| Jun 30, 2023 | -236.09 |
| Mar 31, 2023 | -220.34 |
| Dec 31, 2022 | -46.28 |
| Sep 30, 2022 | -139.24 |
| Jun 30, 2022 | -2,298.59 |
| Mar 31, 2022 | -6.15 |
| Dec 31, 2021 | -1,446.62 |
| Sep 30, 2021 | -9.00 |
| Jun 30, 2021 | -2.05 |